Oculis Holding AG

Research Oculis Holding AG (OCS) on Bullrun: market cap USD 800.05M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerOCS
ExchangeNASDAQ
CountrySwitzerland
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
Market capUSD 800.05M
Financial periodQ2 2026
RevenueCHF 0
Net income-CHF 9.97M
Free cash flow-CHF 20.25M

Valuation Snapshot

latest market cap is USD 800.05M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	CHF 0	-CHF 98.96M	-CHF 67.69M	n/a	-1.92	CHF 81.33M	CHF 2.31M	CHF 196.07M
FY2024	CHF 0	-CHF 85.78M	-CHF 48.86M	n/a	-2.1	CHF 27.71M	CHF 1.18M	CHF 73.38M
FY2023	n/a	n/a	n/a	n/a	-7.4	CHF 38.33M	CHF 605.00K	CHF 93.73M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-25	USD 800.05M	n/a	n/a	n/a
2025	2025-12-31	USD 1.16B	n/a	n/a	n/a
2024	2024-12-31	USD 742.26M	n/a	n/a	n/a
2023	2023-12-29	USD 409.17M	n/a	n/a	n/a
2022	2022-09-29	n/a	198.2	n/a	n/a
2021	2021-12-31	n/a	107.7	n/a	n/a

About Oculis Holding AG

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease;

Related stock research

Switzerland stocks Switzerland Healthcare stocks A-Z stock index

Other Healthcare stocks

MOLECULAR PARTNERS SF 1 (6ML) AC Immune SA (ACIU) Addex Therapeutics Ltd (ADXN) Bachem Holding AG (BANB) BB Biotech AG (BBZA) Bioversys AG (BIOV) Basilea Pharmaceutica AG (BSLN) CARDERO RESOURCE (CR5) CRISPR Therapeutics AG (CRSP) Idorsia Ltd (IDIA) MoonLake Immunotherapeutics - Class A (MLTX) Molecular Partners AG (MOLN)

Frequently asked questions

What is Oculis Holding AG's market cap?

Oculis Holding AG's market capitalization is USD 800.05M.

What does Oculis Holding AG do?

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally.